The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
Andrew Chow(Merck & Co., Inc., Rahway, NJ, USA (United States)), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), Harsha Sridhar(Memorial Sloan Kettering Cancer Center), Elisa de Stanchina(Memorial Sloan Kettering Cancer Center), Hira Rizvi(Memorial Sloan Kettering Cancer Center), Allison L. Richards(Memorial Sloan Kettering Cancer Center), Nisargbhai Shah(Memorial Sloan Kettering Cancer Center), Levi Mangarin(Memorial Sloan Kettering Cancer Center), Jorge Mansilla‐Soto(Memorial Sloan Kettering Cancer Center), Jacklynn V. Egger(Memorial Sloan Kettering Cancer Center), Viola Allaj(Memorial Sloan Kettering Cancer Center), Amanda Kulick(Memorial Sloan Kettering Cancer Center), Joseph M. Chan(Memorial Sloan Kettering Cancer Center), Barzin Y. Nabet(Gene Therapy Laboratory), Maximiliano Meneses(Memorial Sloan Kettering Cancer Center), Àlvaro Quintanal-Villalonga(Memorial Sloan Kettering Cancer Center), Matthew D. Hellmann(AstraZeneca (United States)), Matthew Wierzbicki(Memorial Sloan Kettering Cancer Center), Glenn Heller(Memorial Sloan Kettering Cancer Center), Anton Dobrin(Memorial Sloan Kettering Cancer Center), Daniel Hirschhorn(Cornell University), Triparna Sen(The Ohio State University), Marissa S. Mattar(Memorial Sloan Kettering Cancer Center), Jedd D. Wolchok(Cornell University), Parvathy Manoj(Memorial Sloan Kettering Cancer Center), Michel Sadelain(Columbia University Irving Medical Center), Metamia Ciampricotti(Memorial Sloan Kettering Cancer Center), Mariana Ward(Memorial Sloan Kettering Cancer Center), Yonit Lavin(Icahn School of Medicine at Mount Sinai), Abigail Farillas(Memorial Sloan Kettering Cancer Center), Christopher A. Klebanoff(Cornell University), Shweta S. Chavan(University of Arkansas for Medical Sciences), Sam E. Tischfield(Memorial Sloan Kettering Cancer Center), Rebecca Landau(Memorial Sloan Kettering Cancer Center), Charlene Kwong(Memorial Sloan Kettering Cancer Center), Xiangnan Guan(Unknown), Michael Liu(Memorial Sloan Kettering Cancer Center), Aliya Holland(Memorial Sloan Kettering Cancer Center), Jessica Yavner(Memorial Sloan Kettering Cancer Center), Fathema Uddin(Memorial Sloan Kettering Cancer Center), Taha Merghoub(Cornell University)
Cited by 123
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k